Search Results - "Velthuizen, Maria E."

Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced? by van Tilborg, Theodora C., Derks-Smeets, Inge A.P., Bos, Anna M.E., Oosterwijk, Jan C., van Golde, Ron J., de Die-Smulders, Christine E., van der Kolk, Lizet E., van Zelst-Stams, Wendy A.G., Velthuizen, Maria E., Hoek, Annemieke, Eijkemans, Marinus J.C., Laven, Joop S.E., Ausems, Margreet G.E.M., Broekmans, Frank J.M.

“…STUDY QUESTION Do BRCA1/2 mutation carriers have a compromised ovarian reserve compared to proven non-carriers, based on serum anti-Müllerian hormone (AMH)…”
Get full text

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations by Brohet, Richard M, Velthuizen, Maria E, Hogervorst, Frans B L, Meijers-Heijboer, Hanne E J, Seynaeve, Caroline, Collée, Margriet J, Verhoef, Senno, Ausems, Margreet G E M, Hoogerbrugge, Nicoline, van Asperen, Christi J, Gómez García, Encarna, Menko, Fred, Oosterwijk, Jan C, Devilee, Peter, van't Veer, Laura J, van Leeuwen, Flora E, Easton, Douglas F, Rookus, Matti A, Antoniou, Antonis C

“…BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks have been found to vary across studies and populations. We ascertained…”
Get more information